Pfizer said on Nov. 5 that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90%.
Coronavirus
Deutsche Welle: Pfizer claims COVID-19 pill cuts risk of severe COVID by 89%

People walk by the Pfizer headquarters on Nov. 9, 2020 in New York City.